e-Edition
Obituaries
Photo Gallery
Magazines
News Crew
Paywall Login
Login to Comment
Register
December 15th, 2015
Menu
Home
News
Sports
Business
Entertainment
Federal Election
Classifieds
Life
Commentary
Contact
Local News
Provincial News
National News
World News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Ziopharm Oncology IN
(NQ:
ZIOP
)
4.235
USD
+0.685 (+19.30%)
Official Closing Price
Updated: 7:55 PM EST, Jan 27, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Ziopharm Oncology IN
< Previous
1
2
3
4
5
6
7
8
9
...
47
48
Next >
Ziopharm Oncology Announces Election of James Huang as Chairman of the Board of Directors
January 14, 2021
From
GlobeNewswire News Releases
XBI's Holdings Could Mean 41% Gain Potential
January 07, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Ziopharm to Participate in Upcoming January Conferences
December 23, 2020
From
GlobeNewswire News Releases
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 22, 2020
Gainers Hepion Pharmaceuticals (NASDAQ:HEPA) stock rose 17.92% to $2.5 during Tuesday's pre-market session. The ...
Tags
TLSA
PTE
BZI/TFM
From
Benzinga
The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes
December 22, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
NK
TECH
Pre/Market Outlook
From
Benzinga
42 Stocks Moving in Tuesday's Pre-Market Session
December 22, 2020
Gainers Aurora Mobile Limited (NASDAQ: JG) shares rose 56.4% to $4.99 in pre-market trading after the company reported a ...
Tags
EYEG
QS
Markets
From
Benzinga
7 Stocks Moving In Monday's After-Hours Session
December 21, 2020
Gainers ZIOPHARM Oncology (NASDAQ: ZIOP) shares are trading higher after the company announced clearance of Taiwan's first IND ...
Tags
VERO
Penny Stocks
Trading Ideas
From
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 21, 2020
Gainers electroCore (NASDAQ:ECOR) shares increased by 16.56% to $1.9 during Monday's after-market session. Today's trading ...
Tags
After/Hours Center
DARE
Movers
From
Benzinga
Ziopharm Oncology Announces Clearance of Taiwan’s First IND of Non-viral CAR-T for the Treatment of Relapsed CD19+ Leukemias and Lymphomas
December 21, 2020
From
GlobeNewswire News Releases
The Best Day Trading Stocks In 2021
December 20, 2020
One of the most essential skills of a trader is the ability to pick good day trading stocks. Trading is not only about buying and selling stock the same day but ensuring liquidity and high-risk reward...
Tags
Utilities
Financial
Consumer Goods
From
Blogs - TalkMarkets
WaterMill Asset Management Issues Statement Regarding Consent Solicitation at Ziopharm Oncology
December 17, 2020
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), a sizable and long-term shareholder of Ziopharm Oncology, Inc. (NASDAQ: ZIOP) (“Ziopharm” or the “Company”), today...
From
Business Wire News Releases
The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut
December 17, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ABBV
OTIC
NBTX
From
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 16, 2020
Gainers Evolus (NASDAQ:EOLS) stock moved upwards by 35.69% to $4.98 during Wednesday's after-market session. Trading volume for ...
Tags
SCYX
Health Care
LXRX
From
Benzinga
Ziopharm Comments on Consent Solicitation Results
December 16, 2020
Jaime Vieser and Holger Weis Elected to Board of Directors
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
December 15, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
AGIO
ARVN
OCUL
From
Benzinga
12 Healthcare Stocks Moving In Monday's After-Market Session
December 14, 2020
Gainers Opiant Pharmaceuticals (NASDAQ:OPNT) stock increased by 38.38% to $11.5 during Monday's after-market session. Opiant ...
Tags
MIRM
BLRX
Health Care
From
Benzinga
Ziopharm Oncology Announces Chief Financial Officer to Step Down
December 14, 2020
From
GlobeNewswire News Releases
WaterMill Asset Management Addresses Ziopharm Oncology’s Latest Distortion and Recent Threat
December 12, 2020
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”) today responded to the latest element of the low-road campaign that Ziopharm Oncology, Inc. (NASDAQ: ZIOP)...
From
Business Wire News Releases
Ziopharm Comments on Delay of WaterMill’s Stated Consent Deadline
December 11, 2020
From
GlobeNewswire News Releases
Egan-Jones Recommends Against Electing Dissident’s Full Slate of Nominees to Ziopharm Board
December 10, 2020
From
GlobeNewswire News Releases
WaterMill Asset Management Reinforces the Need for Meaningful and Urgent Change at Ziopharm Oncology
December 08, 2020
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of...
From
Business Wire News Releases
Ziopharm Details Actions in Response to Shareholder Feedback
December 04, 2020
From
GlobeNewswire News Releases
We Did The Math XBI Can Go To $180
December 03, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Glass Lewis Recommends Ziopharm Shareholders Vote on the WHITE Consent Card for All of WaterMill’s Director Candidates and Proposals
December 02, 2020
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”) today announced that Glass, Lewis & Co., LLC (“Glass Lewis”), a leading proxy advisory firm, has endorsed its case...
From
Business Wire News Releases
WaterMill Asset Management Refutes Ziopharm Oncology’s Desperate, Low-Road Smear Campaign
November 28, 2020
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of...
From
Business Wire News Releases
Ziopharm Comments on Institutional Shareholder Services’ Recommendation to Reject WaterMill’s Attempt to Remove Half of Ziopharm’s Board of Directors
November 27, 2020
From
GlobeNewswire News Releases
ISS Recommends Ziopharm Shareholders Vote for Change on WaterMill Asset Management’s WHITE Consent Card
November 25, 2020
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of...
From
Business Wire News Releases
WaterMill Asset Management Sets the Record Straight Following Ziopharm’s Apparent Attempt to Mislead Shareholders and Rewrite History
November 24, 2020
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of...
From
Business Wire News Releases
Ziopharm Releases Investor Presentation Highlighting Execution of Strategy and Substantial Board Refreshment to Enhance Shareholder Value
November 20, 2020
From
GlobeNewswire News Releases
WaterMill Asset Management Releases Presentation Detailing the Case for Urgent Change Atop Ziopharm Oncology
November 19, 2020
WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”), which collectively with the other participants in its consent solicitation beneficially owns approximately 3.3% of...
From
Business Wire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
47
48
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.